Development of an explainable machine learning model for Alzheimer’s disease prediction using clinical and behavioural features

Development of an explainable machine learning model for Alzheimer’s disease prediction using clinical and behavioural features

This article presents a reproducible machine learning methodology for the early prediction of Alzheimer’s disease (AD) using clinical and behavioural data. A comparative analysis of multiple classification algorithms was conducted, with the Gradient Boosting classifier yielding the best performance...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajkumar Govindarajan, K. Thirunadanasikamani, Komal Kumar Napa, S. Sathya, J. Senthil Murugan, K. G. Chandi Priya
Format: Article
Language:English
Published: Elsevier 2025-12-01
Series:MethodsX
Subjects:
Alzheimer's disease prediction
Explainable artificial intelligence
SHAP values
Gradient boosting classifier
Streamlit web application
Online Access:http://www.sciencedirect.com/science/article/pii/S221501612500336X
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article presents a reproducible machine learning methodology for the early prediction of Alzheimer’s disease (AD) using clinical and behavioural data. A comparative analysis of multiple classification algorithms was conducted, with the Gradient Boosting classifier yielding the best performance (accuracy: 93.9 %, F1-score: 91.8 %). To improve interpretability, SHapley Additive exPlanations (SHAP) were integrated into the workflow to quantify feature contributions at both global and individual levels. Key predictive variables such as Mini-Mental State Examination (MMSE), Activities of Daily Living (ADL), cholesterol levels, and functional assessment scores were identified and visualized using SHAP-based insights. A user-friendly, interactive web application was developed using Streamlit, allowing real-time patient data input and transparent model output visualization. This method offers a practical tool for clinicians and researchers to support early diagnosis and personalized risk assessment of AD, thus aiding in timely and informed clinical decision-making.Accurate Prediction: Gradient Boosting model achieved 93.9 % accuracy for early Alzheimer’s detection.Explainability: SHAP values provided interpretable insights into key clinical features.Clinical Tool: A Streamlit-based web app enabled real-time, explainable predictions for users.
ISSN:2215-0161

Similar Items